Heart 98:E150-E151 doi:10.1136/heartjnl-2012-302920e.5
  • Epidemiology, Prevention and Control, Rehabilitation
    • Prevention of cardiovascular disease
  • GW23-e2698


  1. Yuhongxia Yuhongxia
  1. Zhongriyouhao


    Objectives To study the smoking abstinence rate by a group behaviour intervention combine with varenicline.

    Methods Smokers willing to make a quit attempt were randomly allocated, using varenicline combine with a group behaviour intervention smoking cessation programme, or to a control group that received varenicline only to quitting. The primary outcome was 12 weeks self-reported continuous smoking abstinence, biochemically verified by exhaled CO test at 3 months.

    Results We assessed 52 participants for eligibility. Eight were excluded. 27 smokers were allocated to the group behaviour intervention and vanrenicline, another 25 smokers were allocated to the control group; More participants had quit at 4 weeks in the group behaviour intervention compared to the control group: 70.3% vs 52%, p>0.05; 62.9% vs 32% at 12 weeks, p<0.05; Reported quit rates remained high difference at 6 months, but there was some uncertainty about between group differences because of incomplete follow up.

    Conclusions he group behaviour intervention therapy will improve the quit rate with medicine. This study provide a new effective behaviour intervention way to help smokers to quit with medicine.

    Free sample
    This recent issue is free to all users to allow everyone the opportunity to see the full scope and typical content of Heart.
    View free sample issue >>

    Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

    Navigate This Article